Two-year Phase III study shows Novartis oral MS therapy FTY720...

Full story: PR-inside.com

The issuer is solely responsible for the content of this announcement. -------------- * FREEDOMS study shows FTY720 reduced relapse rates by 54-60% compared to placebo, and disability progression by 30-32%[1] * Results build on Phase III TRANSFORMS one-year study showing FTY720 ...

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Avonex, Interferon Beta-1a Discussions

Topic	Updated	Last By	Comments
Don't take Avonex ! (Nov '06)	Nov 30	Maren	30
the auto-injector makes Avonex shots bearable (Jan '06)	Nov '09	Suzanne	7
Whatever Tysabri Outcome, Biogen Idec Should Su...	Nov '09	Sarah	1
how do I quit taking Avones?	Sep '09	MARY	1
low white blood count (May '06)	Dec '08	JAP	3
Leukemia Drug Effective Against MS (Oct '08)	Oct '08	Stephanie	1
Leukemia drug effective against MS (Oct '08)	Oct '08	Deborah Hoffman	2